Concepedia

Erik A. Nelson

EA

Statistics

Publications

29

Citations

2.8K

H-Index

23

Active since

2002

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Dana-Farber Brigham Cancer Center

High Magnetic Field Laboratory

Erik A. Nelson is an author at Dana-Farber Cancer Institute specializing in medicine, molecular oncology, and oncology.

Publications per year

2002–2019

29

Publications

29

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

Emmanuel Zorn, Erik A. Nelson, Mehrdad Mohseni et al. · Blood · 2006 · 735 citations · Full text

, , +14

The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors

Erik A. Nelson, Sarah R. Walker, Ellen Weisberg et al. · Blood · 2011 · 269 citations · Full text

, , +9

Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3

Erik A. Nelson, Sarah R. Walker, Alicia Kepich et al. · Blood · 2008 · 203 citations · Full text

, , +7

Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways

Ayumi Takakura, Erik A. Nelson, Nadeem Haque et al. · Human Molecular Genetics · 2011 · 151 citations · Full text

, , +9

Reciprocal Effects of STAT5 and STAT3 in Breast Cancer

Sarah R. Walker, Erik A. Nelson, Lihua Zou et al. · Molecular Cancer Research · 2009 · 144 citations

, , +11

1–5 of 29